Apoptosis gene signature of Survivin and its splice variant expression in breast carcinoma
Open Access
- 30 August 2011
- journal article
- clinical trial
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 18 (6) , 783-792
Abstract
Survivin, an anti-apoptotic protein, was described as strongly expressed in human cancers including breast cancer. However, little is known about the association between Survivin variants (Survivin-2B, Survivin-ΔEx3, Survivin-3B, and Survivin-2α) and the other apoptotic-related genes. In this study, we analyzed the apoptosis gene signature of Survivin and its variant expression in breast cancer. Human Apoptosis Gene Arrays were used to screen genes that could be associated with Survivin variants. Expression of the five transcripts was measured by RT-PCR in 135 breast carcinomas and Cox survival analysis was analyzed according to the patient outcome. Significant associations between Survivin transcripts and apoptotic genes were found. Interestingly, Survivin-3B variant showed major inverse correlations with pro-apoptotic genes. In addition, in vitro results indicated that overexpression of Survivin-3B strongly inhibits 5-fluorouracil/epirubicin/cyclophosphamide-induced apoptosis in breast tumor cell lines. In breast carcinomas, uni- and multivariate analysis showed patients with high level of Survivin-3B expression had a shorter overall (P=0.030 and P=0.042 respectively), and disease-free (P=0.024 and P=0.009) survival. Our data suggest that Survivin-3B contributes to cell survival through the anti-apoptotic pathway and that its expression level could be an important factor in determining therapeutic strategies for breast carcinoma.Keywords
This publication has 18 references indexed in Scilit:
- Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancerInternational Journal of Colorectal Disease, 2009
- Variations in Gene Expression and Response to Neoadjuvant Chemotherapy in Breast CarcinomaCancer Investigation, 2009
- Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancerEuropean Journal of Surgical Oncology, 2008
- Survivin, cancer networks and pathway-directed drug discoveryNature Reviews Cancer, 2008
- The Survivin Isoform Survivin-3B is Cytoprotective and can Function as a Chromosomal Passenger Complex ProteinCell Cycle, 2007
- Survivin 2α: a novel Survivin splice variant expressed in human malignanciesMolecular Cancer, 2005
- Identification of a novel splice variant of the human anti-apoptopsis gene survivinBiochemical and Biophysical Research Communications, 2004
- Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progressionBritish Journal of Cancer, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- A novel anti-apoptosis gene, survivin, expressed in cancer and lymphomaNature Medicine, 1997